Skip to Main Content

Author Details

Shaham Beg
New York-Presbyterian Hospital-Weill Cornell Medical College
2008
32
14
PMIDPaper TitleJournal TitlePublished Year
36372672Analysis of a pre-2017 follicular variant papillary thyroid carcinoma cohort reclassified as noninvasive follicular thyroid neoplasm with papillary-like features (NIFTP): an 11-year retrospective single institution experience.J Am Soc Cytopathol2023
37419704Optimal fluid volume for detecting malignancy in serous effusions: a single institution experience.J Am Soc Cytopathol2023
34508546NR4A3 Immunostain Is a Highly Sensitive and Specific Marker for Acinic Cell Carcinoma in Cytologic and Surgical Specimens.Am J Clin Pathol2022
35617398Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets.Science2022
35510953Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.J Exp Med2022
35050902Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci.JCI Insight2022
34962713Combining molecular testing and the Bethesda category III:VI ratio for thyroid fine-needle aspirates: A quality-assurance metric for evaluating diagnostic performance in a cytopathology laboratory.Cancer Cytopathol2022
35230579RET Fusion-Positive Papillary Thyroid Cancers are Associated with a More Aggressive Phenotype.Ann Surg Oncol2022
33190043Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology.Transl Oncol2021
34286887Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing.Oncologist2021
32493417Fusions involving BCOR and CREBBP are rare events in infiltrating glioma.Acta Neuropathol Commun2020
31592503Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.JCO Precis Oncol2019
29266381Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.Cancer2018
28893228XIAP over-expression is an independent poor prognostic marker in Middle Eastern breast cancer and can be targeted to induce efficient apoptosis.BMC Cancer2017
27082205Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis.Int J Cancer2016
27236916Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis.Am J Hum Genet2016
26849248Reply to specific gene patterns and molecular pathways related to human carcinogenesis in different populations among various geographic locations.Cancer2016
25712738Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer.Cancer2015
26384210ALK alteration is a frequent event in aggressive breast cancers.Breast Cancer Res2015
26159723Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.Mol Cancer2015
26218848Molecular markers and pathway analysis of colorectal carcinoma in the Middle East.Cancer2015
26023849Dual Targeting of mTOR Activity with Torin2 Potentiates Anticancer Effects of Cisplatin in Epithelial Ovarian Cancer.Mol Med2015
25989274PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma.Br J Cancer2015
25981902Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer.Breast Cancer Res Treat2015
25974735Role of X-Linked Inhibitor of Apoptosis as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.J Clin Endocrinol Metab2015
25005754A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma.Mol Cancer2014
21932352Erythema nodosum leprosum: report of two cases.Diagn Cytopathol2013
21947360Endometrial adenocarcinoma with osteoclastic giant cells in stroma: a case report and review of literature.Arch Gynecol Obstet2012
22787293A comparison of cytological and histopathological findings and role of immunostains in the diagnosis of soft tissue tumors.J Cytol2012
22925468Bilateral, multicenteric metanephric adenoma associated with Wilms' tumor in a child: a rare presentation with important diagnostic and therapeutic implications.Int J Urol2012
21713154Mucinous carcinoma in a male breast.J Cytol2011
18603691Spindle cell lipoma breast.Indian J Pathol Microbiol2008
  • 1 - 32 of 32

Recommended Authors

Pathology Associates at Beverly Hospital
Career Start Year 2017
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2014
Number of shared co-authors 4
Korea University Anam Hospital, Korea University College of Medicine
Career Start Year 2012
Number of shared co-authors 0
Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea
Career Start Year 2008
Number of shared co-authors 0
University of Basel
Career Start Year 2008
Number of shared co-authors 12
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 2
University of Cincinnati College of Medicine
Career Start Year 2007
Number of shared co-authors 2
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year 2005
Number of shared co-authors 2
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
University of Pittsburgh
Career Start Year 2003
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Diagnostic and Research Institute of Pathology, Medical University of Graz
Career Start Year 2003
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 9
The University of Texas M. D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Career Start Year 2000
Number of shared co-authors 0
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 0
Health Research Institute Hospital La Fe
Career Start Year 1999
Number of shared co-authors 1
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Career Start Year 1997
Number of shared co-authors 3
Memorial Sloan-Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 16
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
University of British Columbia
Career Start Year 1994
Number of shared co-authors 1
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1993
Number of shared co-authors 1
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 16
The University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 4
University of Michigan ann arbor
Career Start Year 1989
Number of shared co-authors 5
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 0
The Johns Hopkins Hospital
Career Start Year 1987
Number of shared co-authors 7
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 0
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 11

Collaborators

Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 9
Meyer Cancer Center
Co-authored papers 8
Case Western Reserve University
Co-authored papers 7
Institute for Computational Biomedicine
Co-authored papers 7
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers 5
University of Bern
Co-authored papers 5
Montefiore Medical Center/Albert Einstein College of Medicine
Co-authored papers 5
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 5
Dana-Farber Cancer Institute
Co-authored papers 4
Weill Cornell Medical College
Co-authored papers 3
University Hospital Zurich
Co-authored papers 3
Institute for Pathology, University Hospital Schleswig-Holstein
Co-authored papers 3
NewYork-Presbyterian Hospital - Weill Cornell Medicine
Co-authored papers 3
Sandra and Edward Meyer Cancer Center
Co-authored papers 3
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers 3
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers 3
Sandra and Edward Meyer Cancer Center
Co-authored papers 3
Sandra and Edward Meyer Cancer Center
Co-authored papers 3
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 3
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 2
Weill Cornell Medical College
Co-authored papers 2
Columbia University, United States Bureau of Educational and Cultural Affairs Fulbright Program, University of Piraeus, Weill Cornell Medical College, Weill Cornell Medicine
Co-authored papers 2
Memorial Sloan Kettering Cancer Center, USA Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Weill Cornell University
Co-authored papers 2
Weill Cornell Medical Center, NewYork Presbyterian Hospital
Co-authored papers 2
Sandra and Edward Meyer Cancer Center
Co-authored papers 2
Meyer Cancer Center, Englander Institute for Precision Medicine
Co-authored papers 2
Paris Sciences Lettres University PSL, Institut CURIE
Co-authored papers 2
New York-Presbyterian Hospital
Co-authored papers 2
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 2